MCQ Laboratory analysis of the immune response
1. For many uses in the laboratory, polyclonal antibodies work well, but for some types of assays, they lack sufficient ________ because they cross-react with inappropriate antigens.
2. How are monoclonal antibodies produced?
a) Antibody-producing B cells from a mouse are fused with myeloma cells and then the cells are grown in tissue culture.
b) A mouse is injected with an antigen and then antibodies are harvested from its serum.
c) They are produced by the human immune system as a natural response to an infection.
d) They are produced by a mouse’s immune system as a natural response to an infection.
3. The formation of ________ is a positive result in the VDRL test.
d) a bright pink color
4. The titer of a virus neutralization test is the highest dilution of patient serum
a) in which there is no detectable viral DNA.
b) in which there is no detectable viral protein.
c) that completely blocks plaque formation.
d) that reduces plaque formation by at least 50%.
5. In the Ouchterlony assay, we see a sharp precipitin arc form between antigen and antiserum. Why does this arc remain visible for a long time?
a) The antibody molecules are too large to diffuse through the agar.
b) The precipitin lattice is too large to diffuse through the agar.
c) Methanol, added once the arc forms, denatures the protein and blocks diffusion.
d) The antigen molecules are chemically coupled to the gel matrix.
6. We use antisera to distinguish between various ________ within a species of bacteria.
7. When using antisera to characterize bacteria, we will often link the antibodies to ________ to better visualize the agglutination.
a) latex beads
b) red blood cells
c) other bacteria
d) white blood cells
8. The antibody screening test that is done along with pretransfusion blood typing is used to ensure that the recipient
a) does not have a previously undetected bacterial or viral infection.
b) is not immunocompromised.
c) actually does have the blood type stated in the online chart.
d) is not making antibodies against antigens outside the ABO or Rh systems.
9. The direct Coombs’ test is designed to detect when people have a disease that causes them to
a) have an excessively high fever.
b) quit making antibodies.
c) make too many red blood cells.
d) produce antibodies that bind to their own red blood cells.
10. Viral hemagglutination assays only work with certain types of viruses because
a) the virus must be able to crosslink red blood cells directly.
b) the virus must be able to lyse red blood cells.
c) the virus must not be able to lyse red blood cells.
d) other viruses are too dangerous to work with in a clinical lab setting.
11. In an enzyme immunoassay, the enzyme
a) is bound by the antibody’s antigenbinding site.
b) is attached to the well of a microtiter plate.
c) is conjugated to the suspect antigen.
d) is bound to the constant region of the secondary antibody.
12. When using an EIA to study microtubules or other structures inside a cell, we first chemically fix the cell and then treat the cells with alcohol. What is the purpose of this alcohol treatment?
a) It makes holes in the cell membrane large enough for antibodies to pass.
b) It makes the membrane sticky so.antibodies will bind and be taken up by receptor-mediated endocytosis.
c) It removes negative charges from the membrane, which would otherwise repulse the antibodies.
d) It prevents nonspecific binding of the antibodies to the cell membrane.
13. In a lateral-flow pregnancy test, you see a blue band form on the control line and no band form on the test line. This is probably a ________ test for pregnancy.
14. When performing an FEIA, the fluorogen replaces the ________ that is used in an EIA.
b) chromogenic substrate
d) secondary antibody
16. In the data described in the previous question, the average fluorescence intensity of cells in the second (red) peak is about ________ that in the first (blue) peak.
a) three times
b) 100 times
d) 1000 times
17. In a direct fluorescent antibody test, which of the following would we most likely be looking for using a fluorescentlylabeled mAb?
a) bacteria in a patient sample
b) bacteria isolated from a patient and grown on agar plates
c) antiserum from a patient smeared onto a glass slide
d) antiserum from a patient that had bound to antigen-coated beads